Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

500 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A conversation with Arthur Kavanaugh.
Kavanaugh A. Kavanaugh A. Manag Care Interface. 2007 Jul;20(7):26-7, 30. Manag Care Interface. 2007. PMID: 17849730
Biologic therapies play a greater role in the treatment of human autoimmune diseases than they did in the past. Arthur Kavanaugh, MD, Professor of Clinical Medicine, University of California, San Diego, School of Medicine, talked with Managed Care Interface about th …
Biologic therapies play a greater role in the treatment of human autoimmune diseases than they did in the past. Arthur Kavanaugh
Alterations in immune function with biologic therapies for autoimmune disease.
Her M, Kavanaugh A. Her M, et al. Among authors: kavanaugh a. J Allergy Clin Immunol. 2016 Jan;137(1):19-27. doi: 10.1016/j.jaci.2015.10.023. J Allergy Clin Immunol. 2016. PMID: 26768759 Review.
Tumor necrosis factor as a therapeutic target of rheumatologic disease.
Ackermann C, Kavanaugh A. Ackermann C, et al. Among authors: kavanaugh a. Expert Opin Ther Targets. 2007 Nov;11(11):1369-84. doi: 10.1517/14728222.11.11.1369. Expert Opin Ther Targets. 2007. PMID: 18028004 Review.
B cell targeted therapies: safety considerations.
Kavanaugh AF. Kavanaugh AF. J Rheumatol Suppl. 2006 May;77:18-23. J Rheumatol Suppl. 2006. PMID: 16652441 Review.
Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines.
Kavanaugh AF, Ritchlin CT; GRAPPA Treatment Guideline Committee. Kavanaugh AF, et al. J Rheumatol. 2006 Jul;33(7):1417-21. Epub 2006 May 15. J Rheumatol. 2006. PMID: 16724373 Review.
Therapies for psoriatic nail disease. A systematic review.
Cassell S, Kavanaugh AF. Cassell S, et al. J Rheumatol. 2006 Jul;33(7):1452-6. Epub 2006 May 15. J Rheumatol. 2006. PMID: 16724366 Review.
Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.
Kavanaugh A, McInnes I, Mease P, Krueger GG, Gladman D, Gomez-Reino J, Papp K, Zrubek J, Mudivarthy S, Mack M, Visvanathan S, Beutler A. Kavanaugh A, et al. Arthritis Rheum. 2009 Apr;60(4):976-86. doi: 10.1002/art.24403. Arthritis Rheum. 2009. PMID: 19333944 Clinical Trial.
Golimumab in the treatment of psoriatic arthritis.
Love TJ, Kavanaugh A. Love TJ, et al. Among authors: kavanaugh a. Expert Rev Clin Immunol. 2018 Nov;14(11):893-898. doi: 10.1080/1744666X.2018.1524755. Epub 2018 Sep 27. Expert Rev Clin Immunol. 2018. PMID: 30221556 Review.
Novel Treatment Concepts in Psoriatic Arthritis.
Boyd T, Kavanaugh A. Boyd T, et al. Among authors: kavanaugh a. Rheum Dis Clin North Am. 2015 Nov;41(4):739-54. doi: 10.1016/j.rdc.2015.07.011. Epub 2015 Aug 30. Rheum Dis Clin North Am. 2015. PMID: 26476230 Review.
Editorial: pregnancy and rheumatoid arthritis - do not let the perfect become the enemy of the good.
Cush JJ, Kavanaugh A. Cush JJ, et al. Among authors: kavanaugh a. Curr Opin Rheumatol. 2014 May;26(3):299-301. doi: 10.1097/BOR.0000000000000061. Curr Opin Rheumatol. 2014. PMID: 24667288 No abstract available.
500 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback